Showing results (111-120 of 142) with videos related to
Sort By:
Pageof 15
The Journal of Biological Chemistry|October 6, 2005
The CATERPILLER protein monarch-1 is an antagonist of toll-like receptor-, tumor necrosis factor alpha-, and Mycobacterium tuberculosis-induced pro-inflammatory signalsKristi L Williams, John D Lich, Joseph A Duncan, et al.Nutrition and Cancer|April 30, 2008
Ursodeoxycholic acid suppresses Cox-2 expression in colon cancer: roles of Ras, p38, and CCAAT/enhancer-binding proteinSharad Khare, Reba Mustafi, Sonia Cerda, et al.Immunity|December 17, 2017
Oncogenic RAS Signaling Promotes Tumor Immunoresistance by Stabilizing PD-L1 mRNAMatthew A Coelho, Sophie de Carné Trécesson, Sareena Rana, et al.Cancer Research|April 18, 2024
CRISPR-Cas9 Screening Identifies KRAS-Induced COX2 as a Driver of Immunotherapy Resistance in Lung CancerJesse Boumelha, Andrea de Castro, Nourdine Bah, et al.The Journal of Foot and Ankle Surgery : Official Publication of the American College of Foot and Ankle Surgeons|February 7, 2007
Diabetic foot disorders. A clinical practice guideline (2006 revision)Robert G Frykberg, Thomas Zgonis, David G Armstrong, et al.Plos One|July 15, 2015
Sedimentation Pulse in the NE Gulf of Mexico following the 2010 DWH BlowoutGregg R Brooks, Rebekka A Larson, Patrick T Schwing, et al.Nature Communications|September 25, 2024
Combining RAS(ON) G12C-selective inhibitor with SHP2 inhibition sensitises lung tumours to immune checkpoint blockadePanayiotis Anastasiou, Christopher Moore, Sareena Rana, et al.Nature Communications|November 28, 2022
Lysosomal damage drives mitochondrial proteome remodelling and reprograms macrophage immunometabolismClaudio Bussi, Tiaan Heunis, Enrica Pellegrino, et al.Cancer Research|June 8, 2026
KRAS Inhibitor Induced Cancer Cell Death Enhances Sensitivity to Immune-Mediated Bystander Killing of Drug-Resistant SubclonesMona Tomaschko, KangBo Ng, Christopher Moore, et al.Cancer Cell|July 2, 2019
RAC1<sup>P29S</sup> Induces a Mesenchymal Phenotypic Switch via Serum Response Factor to Promote Melanoma Development and Therapy ResistanceDaniël A Lionarons, David C Hancock, Sareena Rana, et al.Pageof 15